ZENO - Zenosense, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.01 (+3.13%)
At close: 3:48PM EDT
Stock chart is not supported by your current browser
Previous Close0.32
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Avg. Volume113,776
Market Cap10.252M
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire21 days ago

    Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million

    VALENCIA, SPAIN, Sept. 05, 2018-- via NEWMEDIAWIRE-- Zenosense, Inc., a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the ...

  • Zacks Small Cap Research2 months ago

    Zenosense’s MIDS Cardiac Could Revolutionize Cardiac Troponin Testing

    OTC:ZENO Zenosense, Inc. (OTC:ZENO) is a healthcare technology company located in Valencia, Spain.  The company’s main focus is a novel hand-held point-of-care (POC) cardiac diagnostic device called MIDS ...

  • GlobeNewswire3 months ago

    Zenosense Trading on the OTCQB Venture Market

    Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held device for the early detection of heart attack at the Point of Care, is pleased to announce that the Company is now trading on the OTC Markets Group OTCQB “Venture Market”. The OTCQB is recognized as an Established Public Market by the U.S. Securities and Exchange Commission and is a leading market for entrepreneurial and development stage U.S. and international companies.

  • Newsfile3 months ago

    NetworkNewsAudio Announces Audio Press Release (APR) on Zenosense Demonstrating Impressive Results with MIDS Cardiac

    New York, New York--(Newsfile Corp. - June 28, 2018) - NetworkNewsAudio announces the Audio Press Release (APR) titled "Diagnostics Play Critical Role in Medical Sector," featuring Zenosense (OTC Pink: ZENO). To hear the NetworkNewsAudio version, visit http://nnw.fm/kqyU7To read the original editorial, visit http://nnw.fm/8ZAlrDeveloped by the Company's MIDS Medical Limited joint venture (MML) based at the prestigious Sci-Tech Daresbury campus in the United Kingdom, MIDS Cardiac is a handheld POC technology for the detection of ...

  • Marketwired10 months ago

    Zenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test Results

    Zenosense, Inc. , a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care handheld device for the early detection of certain cardiac ...